0001517026-21-000009.txt : 20211012
0001517026-21-000009.hdr.sgml : 20211012
20211012165555
ACCESSION NUMBER: 0001517026-21-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211009
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verratti Mark
CENTRAL INDEX KEY: 0001517026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 211319167
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SATL LAKE CITY
STATE: UT
ZIP: 84003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-10-09
0
0000899923
MYRIAD GENETICS INC
MYGN
0001517026
Verratti Mark
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
President, Myriad Neuroscience
Common Stock
2021-10-09
4
F
0
3349
30.88
D
199010
D
Common Stock
2021-10-09
4
F
0
4991
30.88
D
194019
D
Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.
Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.
By: Nathan A. Smith For: Mark Verratti
2021-10-12